A compound from the South African toothbrush tree inactivates a drug target for tuberculosis in a previously unseen way.
5 / 5 (1) |
0
|
Researchers have discovered a new compound that restores the health of mice infected with methicillin-resistant Staphylococcus aureus (MRSA), an otherwise dangerous bacterial infection. The new compound targets ...
5 / 5 (3) |
1
|
A team, led by senior author Morris J. Birnbaum, MD, PhD, the Willard and Rhoda Ware Professor of Medicine, with the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University ...
5 / 5 (3) |
0
|
Even as epidemiologists worry about a shrinking arsenal of antibiotics to fight potentially deadly drug-resistant bacteria, researchers at Johns Hopkins Hospital are betting on another weapon to prevent infections: robots.
5 / 5 (2) |
0
In Ethiopia, where more than 1.2 million people are infected with HIV, disclosure of infection by patients is important in the fight against the disease. A new study led by a Brown sociology researcher investigates HIV-positive ...
not rated yet |
0
Infection control experts at The Johns Hopkins Hospital have found that a combination of robot-like devices that disperse a bleaching agent into the air and then detoxify the disinfecting chemical are highly effective at ...
5 / 5 (10) |
4
|
The newly appointed deputy chief of the United Nations HIV-fighting program, Brazilian Luiz Loures, hailed his own country's achievements in the fight against the deadly global epidemic in an interview published Saturday.
not rated yet |
0
A novel approach to identifying potential anticancer drug combinations revealed that pairing cholesterol-reducing drugs called statins with cyclin-dependent kinase inhibitors might provide an effective approach to treating ...
not rated yet |
0
Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug ...
not rated yet |
0
Despite treatment with imatinib, a successful drug that targets chronic myeloid leukemia (CML), a deadly type of cancer, some patients may continue to be at risk for relapse because a tiny pool of stem cells is resistant ...
5 / 5 (3) |
0
|
More than half of all patients with ovarian cancer experience recurrent disease and will eventually fail to respond to chemotherapy. The failure of chemotherapy is usually due to the development of resistance to the two main ...
not rated yet |
0
(Medical Xpress)—A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia microbiologists.
4.5 / 5 (2) |
0
|
Cancer therapies often have short-lived benefits due to the emergence of genetic mutations that cause drug resistance. A key gene that determines resistance to a range of cancer drugs has been reported in a study published ...
not rated yet |
0
|
Unraveling the mechanism that ovarian cancer cells use to change normal cells around them into cells that promote tumor growth has identified several new targets for treatment of this deadly disease.
5 / 5 (2) |
0
|
(Medical Xpress)—HIV-positive individuals who strictly adhere to highly active antiretroviral therapy (HAART) have a significantly lower probability of premature morbidity and mortality as compared to those with suboptimal ...
not rated yet |
0
|
